Principal Investigator
Terisa
Davis
Awardee Organization
University of Alabama
United States
Fiscal Year
2013
NIH RePORTER
For more information, see NIH RePORTER Project 261201200021I-0-26100004-1
Evaluation of GLG-302, a STAT3 Antagonist, in the Prevention of Mammary Cancer
The primary goal of this task order is to determine whether GLG-302 (an inhibitor of STAT3 signaling) has cancer chemopreventive efficacy in preclinical models of breast cancer.